Jane Chung - Aug 10, 2022 Form 3 Insider Report for Viracta Therapeutics, Inc. (VIRX)

Role
Director
Signature
/s/ Daniel Chevallard, as Attorney-in-Fact
Stock symbol
VIRX
Transactions as of
Aug 10, 2022
Transactions value $
$0
Form type
3
Date filed
8/11/2022, 06:47 PM
Previous filing
Aug 10, 2022
Next filing
Mar 7, 2023

No securities are beneficially owned.

Remarks:

No securities beneficially held.